BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38373870)

  • 41. Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?
    Ignatavicius P; Oberkofler CE; Chapman WC; DeMatteo RP; Clary BM; D'Angelica MI; Tanabe KK; Hong JC; Aloia TA; Pawlik TM; Hernandez-Alejandro R; Shah SA; Vauthey JN; Torzilli G; Lang H; Line PD; Soubrane O; Pinto-Marques H; Robles-Campos R; Boudjema K; Lodge P; Adam R; Toso C; Serrablo A; Aldrighetti L; DeOliveira ML; Dutkowski P; Petrowsky H; Linecker M; Reiner CS; Braun J; Alikhanov R; Barauskas G; Chan ACY; Dong J; Kokudo N; Yamamoto M; Kang KJ; Fong Y; Rela M; De Aretxabala X; De Santibañes E; Mercado MÁ; Andriani OC; Torres OJM; Pinna AD; Clavien PA
    Ann Surg; 2020 Nov; 272(5):715-722. PubMed ID: 32833764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis.
    Montalti R; Berardi G; Laurent S; Sebastiani S; Ferdinande L; Libbrecht LJ; Smeets P; Brescia A; Rogiers X; de Hemptinne B; Geboes K; Troisi RI
    Eur J Surg Oncol; 2014 May; 40(5):536-544. PubMed ID: 24555996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study.
    Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B
    ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
    Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Up front hepatectomy for metastatic rectal carcinoma - reversed, liver first approach. Early experience with 15 patients.
    Straka M; Skrovina M; Soumarova R; Kotasek R; Burda L; Vojtek C
    Neoplasma; 2014; 61(4):447-52. PubMed ID: 25027742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
    Shah K; Clary B
    Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
    Schwarz RE; Berlin JD; Lenz HJ; Nordlinger B; Rubbia-Brandt L; Choti MA
    HPB (Oxford); 2013 Feb; 15(2):106-15. PubMed ID: 23297721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
    Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current landscape of preoperative neoadjuvant therapies for initial resectable colorectal cancer liver metastasis.
    Cheng XF; Zhao F; Chen D; Liu FL
    World J Gastroenterol; 2024 Feb; 30(7):663-672. PubMed ID: 38515943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
    J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features.
    Germani MM; Borelli B; Boraschi P; Antoniotti C; Ugolini C; Urbani L; Morelli L; Fontanini G; Masi G; Cremolini C; Moretto R
    Cancer Treat Rev; 2022 May; 106():102382. PubMed ID: 35334281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Making unresectable hepatic colorectal metastases resectable--does it work?
    Vauthey JN; Zorzi D; Pawlik TM
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S118-22. PubMed ID: 16399448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes.
    Elfrink AKE; Kok NFM; van der Werf LR; Krul MF; Marra E; Wouters MWJM; Verhoef C; Kuhlmann KFD; den Dulk M; Swijnenburg RJ; Te Riele WW; van den Boezem PB; Leclercq WKG; Lips DJ; Nieuwenhuijs VB; Gobardhan PD; Hartgrink HH; Buis CI; Grünhagen DJ; Klaase JM; ;
    Eur J Surg Oncol; 2020 Sep; 46(9):1742-1755. PubMed ID: 32303416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.